The Food and Drug Administration on Thursday cut in half the recommended dose of the popular sleeping pill Lunesta, concluding some patients were impaired the morning after taking it even if they felt fully awake.. Lunesta, made by the Sunovion Pharmaceuticals unit of Japan's Dainippon Sumitomo Pharma Co. Ltd., generated U.S. sales in 2013 of $867 million, according to IMS Health. The drug made its debut in 2005.. The...
  